• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏肥胖是活体肝移植术中高术中出血量的独立危险因素;术前康复和营养治疗可以降低这种风险吗?

Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk?

机构信息

Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Hepato-Pancreato-Biliary Surgery, National Liver Institute, Menoufia University, Egypt.

Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Gastroenterological and General Surgery, St. Luke's International Hospital, Tokyo, Japan.

出版信息

Clin Nutr. 2021 Mar;40(3):956-965. doi: 10.1016/j.clnu.2020.06.023. Epub 2020 Jul 1.

DOI:10.1016/j.clnu.2020.06.023
PMID:32665100
Abstract

BACKGROUND & AIMS: Blood loss during liver transplantation (LT) is one of the major concerns of the transplant team, given the potential negative post-transplant outcomes related to it. Blood loss was reported to be higher in certain body compositions, such as obese patients, undergoing LT. Therefore, we aimed to study the risk factors for high blood loss (HBL) during adult living donor liver transplant (ALDLT) including the body composition markers; visceral-to-subcutaneous adipose tissue area ratio (VSR), skeletal muscle index and intramuscular adipose tissue content. In June 2015, an aggressive perioperative rehabilitation and nutritional therapy (APRNT) program was prescribed in our institute for the patients with abnormal body composition.

METHODS

We retrospectively analyzed 394 patients who had undergone their first ALDLT between 2006 and 2019. Risk factors for HBL were analyzed in the total cohort. Differences in blood loss and risk factors were analyzed in relation to the APRNT.

RESULTS

Multivariate risk factor analysis in the total cohort showed that a high VSR (odds ratio (OR): 1.98, 95% confidence interval (CI): 1.19-3.29, P = 0.009), was an independent risk factor for HBL during ALDLT, as well as a history of upper abdominal surgery, simultaneous splenectomy and the presence of a large amount of ascites. After the introduction of the APRNT, a significantly lower blood loss was observed during the ALDLT recipient operation (P = 0.003). Moreover, the significant difference in blood loss observed between normal and high VSR groups before the application of the APRNT (P < 0.001), was not observed with the APRNT (P = 0.85). Likewise, before the APRNT, only high VSR was a risk factor for HBL by multivariate analysis (OR: 2.34, CI: 1.33-4.09, P = 0.003). Whereas with the APRNT, high VSR was no longer a significant risk factor for HBL even by univariate analysis (OR: 0.89, CI: 0.26-3.12, P = 0.86).

CONCLUSION

Increased visceral adiposity was an independent risk factor for high intraoperative blood loss during ALDLT recipient operation. With APRNT, high VSR was not associated with high blood loss. Therefore, APRNT might have mitigated the risk of high blood loss related to high visceral adiposity.

摘要

背景与目的

肝移植(LT)过程中的失血是移植团队关注的主要问题之一,因为与之相关的移植后潜在负面结果。据报道,某些体型的患者(如肥胖患者)在接受 LT 时失血更多。因此,我们旨在研究成人活体供肝移植(ALDLT)过程中高失血(HBL)的危险因素,包括体成分标志物;内脏-皮下脂肪组织面积比(VSR)、骨骼肌指数和肌肉内脂肪含量。2015 年 6 月,我们所在的研究所对体型异常的患者采用了积极的围手术期康复和营养治疗(APRNT)方案。

方法

我们回顾性分析了 2006 年至 2019 年间首次接受 ALDLT 的 394 例患者。对总队列中 HBL 的危险因素进行了分析。分析了 APRNT 相关的失血和危险因素的差异。

结果

多变量风险因素分析显示,高 VSR(比值比(OR):1.98,95%置信区间(CI):1.19-3.29,P=0.009)是 ALDLT 期间 HBL 的独立危险因素,而上腹部手术史、同时行脾切除术和大量腹水的存在也是 HBL 的独立危险因素。在 APRNT 引入后,ALDLT 受体手术中的出血量明显减少(P=0.003)。此外,在应用 APRNT 之前,VSR 正常和高的两组之间观察到的显著的出血量差异(P<0.001),在应用 APRNT 后并不明显(P=0.85)。同样,在 APRNT 之前,只有高 VSR 是多变量分析中的 HBL 危险因素(OR:2.34,CI:1.33-4.09,P=0.003)。然而,在 APRNT 之后,即使是单变量分析,高 VSR 也不再是 HBL 的显著危险因素(OR:0.89,CI:0.26-3.12,P=0.86)。

结论

内脏脂肪增加是 ALDLT 受体手术中术中失血过多的独立危险因素。通过 APRNT,高 VSR 与高出血量无关。因此,APRNT 可能减轻了与内脏脂肪过多相关的高出血风险。

相似文献

1
Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk?内脏肥胖是活体肝移植术中高术中出血量的独立危险因素;术前康复和营养治疗可以降低这种风险吗?
Clin Nutr. 2021 Mar;40(3):956-965. doi: 10.1016/j.clnu.2020.06.023. Epub 2020 Jul 1.
2
Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.骨骼肌质量指数、肌内脂肪组织含量及内脏与皮下脂肪组织面积比 对活体肝移植早期死亡率的影响
Transplantation. 2017 Mar;101(3):565-574. doi: 10.1097/TP.0000000000001587.
3
Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation.提出新的选择标准,考虑活体肝移植前的肌肉质量和内脏脂肪。
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):246-254. doi: 10.1002/jcsm.12276. Epub 2018 Feb 17.
4
Changes in Muscle Quality and Body Composition 1 Year After Hand-Assisted Laparoscopic Donor Nephrectomy in Living Kidney Donors.活体供肾者手助腹腔镜供肾切除术后 1 年肌肉质量和身体成分的变化。
Exp Clin Transplant. 2020 Nov;18(6):682-688. doi: 10.6002/ect.2020.0027. Epub 2020 Aug 14.
5
Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.将人体成分纳入 MELD 评分可提高肝移植等待患者的死亡率预测。
Clin Nutr. 2020 Jun;39(6):1885-1892. doi: 10.1016/j.clnu.2019.08.012. Epub 2019 Aug 21.
6
Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.内脏肥胖及肌肉减少症因素对接受结直肠癌肝转移肝切除术患者预后的影响。
World J Surg. 2018 Apr;42(4):1180-1191. doi: 10.1007/s00268-017-4255-5.
7
Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.肌少症性肥胖对活体供肝移植患者结局的影响。
Clin Nutr. 2019 Oct;38(5):2202-2209. doi: 10.1016/j.clnu.2018.09.019. Epub 2018 Sep 28.
8
Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation.肝移植术后肝细胞癌患者内脏肥胖与肿瘤复发的关系。
Int J Obes (Lond). 2023 Dec;47(12):1214-1223. doi: 10.1038/s41366-023-01367-5. Epub 2023 Aug 28.
9
Visceral adiposity in cirrhosis: Association with disease severity and impact of liver transplantation.肝硬化内脏性肥胖:与疾病严重程度的关系及肝移植的影响。
Hepatol Commun. 2023 May 15;7(6). doi: 10.1097/HC9.0000000000000113. eCollection 2023 Jun 1.
10
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.肌肉减少症、肌肉内脂肪沉积和内脏肥胖独立预测肝细胞癌的结局。
J Hepatol. 2015 Jul;63(1):131-40. doi: 10.1016/j.jhep.2015.02.031. Epub 2015 Feb 24.

引用本文的文献

1
High visceral adipose tissue area is independently associated with early allograft dysfunction in liver transplantation recipients: a propensity score analysis.高内脏脂肪组织面积与肝移植受者早期移植肝功能障碍独立相关:一项倾向评分分析。
Insights Imaging. 2022 Oct 11;13(1):165. doi: 10.1186/s13244-022-01302-8.